SlideShare a Scribd company logo
CEREBRAL EDEMA
GUIDE: DR.NAVEEN ANGADI
CO-GUIDE: DR. ARCHANA UPPIN
• Brain tissue, which is composed of 80% water, is separated from the systemic circulation by a
complex series of interfaces.
• The major site is the endothelial cells that are a component of the neurovascular unit
• Cells that form these interfaces have specialized proteins that form tight junctions; some have
carrier proteins that shuttle essential molecules, and multiple electrolyte pumps on cell
membranes.
• Cellular membranes preserve the compartmental structure with water in extracellular and
intracellular spaces.
INTRODUCTION
Bradley’s Neurology in Clinical Practice,6th
THE NEURO-VASCULAR UNIT
Bradley’s Neurology in Clinical Practice,6th
Interface Tight-Junction
Location
Functional Aspects
Blood-CSF Choroid plexus
cell
Active secretion of CSF
via ATPase and carbonic
anhydrase
CSF-blood Arachnoid
membrane
Arachnoid granulations
absorb CSF by one-way
valve mechanism
Blood-brain Capillary
endothelial cell
Active transport of ISF
via ATPase; increased
mitochondria and
glucose transporters in
capillary endothelial
Bradley’s Neurology in Clinical Practice,6th
ATPase, Adenosine triphosphatase; CSF, cerebrospinal fluid; ISF, interstitial fluid.
• Brain edema is a common term to describe events related to brain insults.
• When shifts in water from one compartment to another occur under pathological
conditions, swelling in the various compartments leads to increased intracranial pressure
(ICP).
• Edema represents a serious, often life threatening consequence of many common brain
disorders including stroke, trauma, tumors, and infection.
• Cerebral edema is the end result of many neurological diseases. Excess fluid can
accumulate in the intracellular or extracellular spaces.
Bradley’s Neurology in Clinical Practice,6th
CLASSIFICATION
• A convenient (though simplified) classification separates brain edema into
Cytotoxic or cellular swelling , and Vasogenic or vascular leakage (Klatzo, 1967).
• Another proposed category is Interstitial edema , which represents the
accumulation of fluid in interstitial spaces in hydrocephalus (Fishman,1975).
Bradley’s Neurology in Clinical Practice,6th
ETIOLOGY
Type Cause
Cytotoxic Ischemia, trauma, toxins, metabolic
diseases
Vasogenic Infections, brain tumors, hyperosmolar
states, inflammation
Interstitial Hydrocephalus with transependymal
flow
Bradley’s Neurology in Clinical Practice,6th
MOLECULAR CASCADE IN INJURY
• Cytotoxic edema, which results from pathological processes that damage cell
membranes, constricts the extracellular spaces, constraining movement of fluid
between the cells.
• Disruption of the BBB leads to vasogenic edema, which expands the extracellular
space. Vasogenic edema moves more readily in between the linearly arranged fibers
that form the white matter. The gray matter restricts water movement because of the
dense nature of the neuropil.
• Because of the lack of cell damage in vasogenic edema, once the damage to the
blood vessel resolves, there may be a return to normal in the edematous tissue. This is
generally not the case in cytotoxic edema, which is due to direct injury to cells.
Bradley’s Neurology in Clinical Practice,6th
MOLECULAR CASCADE IN INJURY
Bradley’s Neurology in Clinical Practice,6th
CYTOTOXIC EDEMA
• Stroke, trauma, and toxins induce cytotoxic edema. After a stroke, brain water
increases rapidly owing to energy failure and loss of ATP. Cytotoxic edema is seen
between 24 and 72 hours after the stroke, when the danger of brain herniation is
greatest.
• Damage to the blood vessels, resulting in vasogenic edema, occurs at multiple times
after the insult. In brain trauma, there is an early opening of the BBB along with
extensive damage to the brain tissue, and a mixture of cytotoxic and vasogenic edema
leads to severe brain edema in the early stages after injury.
• Greater damage occurs in transient ischemia, because the restoration of blood flow
returns oxygen and white blood cells to the region, enhancing the damage.
Reperfusion injury particularly damages the capillary, with disruption of the BBB.
Bradley’s Neurology in Clinical Practice,6th
VASOGENIC EDEMA
• Occurs when there is damage to the capillary and subsequent disruption of the
BBB.
• Tight junctions in the endothelial cells are the first line of protection.
• Protein and blood products enter brain tissue, increasing the oncotic pressure in
the brain and exposing brain cells to toxic products from the blood.
• Bacterial meningitis initiates an inflammatory response in the meninges caused by
the invading organisms and by the secondary release of cytokines and
chemokines. The secondary inflammatory response may aggravate the infection.
Bradley’s Neurology in Clinical Practice,6th
BLOOD PRESSURE AND OSMOLALITY CHANGES ON
BRAIN EDEMA
• Cerebral blood pressure is tightly regulated in the waking state to ensure
adequate flow to the brain. Loss of autoregulation occurs at both the lower and
upper extremes of blood pressure, with resulting syncope and hypertensive
encephalitis, respectively.
• Rapid elevation of blood pressure causes hypertensive encephalopathy. In
experimental animals, hyperemia is present, suggesting that the blood vessels are
dilated and have increased permeability,
• MRI shows vasogenic edema, primarily in the posterior white matter of the brain,
a condition referred to by some as reversible posterior leukoencephalopathy
syndrome,
Bradley’s Neurology in Clinical Practice,6th
BLOOD PRESSURE AND OSMOLALITY CHANGES ON
BRAIN EDEMA
• Another cause of cerebral edema is a rapid change in serum osmolality.
• Rapid reduction of plasma glucose and sodium puts patients treated for diabetic
ketoacidosis at risk for edema secondary to water shifts into the brain.
• Cerebral edema is a complication of acute mountain sickness, which in rare
circumstances may be life threatening. Cerebral symptoms are prominent, and
there is an increase in cerebral blood volume related to the hypoxia.
Bradley’s Neurology in Clinical Practice,6th
EDEMA IN VENOUS OCCLUSION AND
INTRACEREBRAL HEMORRHAGE
• Occlusion of the venous sinuses draining the brain can cause increased ICP and
venous hemorrhagic infarction.
• Intracerebral hemorrhage (ICH) causes brain edema around the hemorrhagic
mass.
• This edema is both cytotoxic and vasogenic.
• Blood contains coagulation cascade enzymes such as thrombin and plasmin
which can damage cells both directly by their toxic effects and indirectly by
activation of other proteases.
Bradley’s Neurology in Clinical Practice,6th
GENERAL MEASURES FOR MANAGING
CEREBRAL EDEMA
1. Optimizing Head and Neck Positions
2. Ventilation and Oxygenation
3. Intravascular Volume and Cerebral Perfusion
4. Seizure Prophylaxis
5. Management of Fever and Hyperglycemia
6. Nutritional Support
Neurosurg Focus 22 (5):E12,2007
OPTIMIZING HEAD AND NECK POSITIONS
• 30 ̊elevation of the head in patients is essential for
1. avoiding jugular compression and impedance of venous outflow from
the cranium
2. for decreasing CSF hydrostatic pressure..
• Head position elevation may be detrimental in ischemic stroke, because
it may compromise perfusion to ischemic tissue at risk.
Neurosurg Focus 22 (5):E12,2007
VENTILATION AND OXYGENATION
• Hypoxia and hypercapnia are potent cerebral vasodilator
• Patient should be intubated in:
1. GCS scores less than or equal to 8
2. Patients with poor upper airway reflexes be intubated
preemptively for airway protection.
3. Aspiration pneumonitis
4. Pulmonary contusion
5. Acute respiratory distress syndrome.
Neurosurg Focus 22 (5):E12,2007
INTRAVASCULAR VOLUME AND
CEREBRAL PERFUSION
• Maintenance of CPP using adequate fluid management in combination with
vasopressors is vital in patients with brain injury
• Hypotonic fluids should be avoided at all cost
• Euvolemia or mild hypervolemia with the use of isotonic fluids (0.9%
saline) should always be maintained through rigorous attention to daily
fluid balance, body weight, and serum electrolyte monitoring.
Neurosurg Focus 22 (5):E12,2007
TREATING HYPERTENSION
• Judicious use of antihypertensives
1. Labetalol
2. Enalapril
3. Nicardipine is recommended for treating systemic hypertension.
• Potent vasodilators are to be avoided
• Nitroglycerine
• Nitroprusside
• as they may exacerbate cerebral edema via accentuated cerebral hyperemia
and CBV due to their direct vasodilating effects on cerebral vasculature.
Neurosurg Focus 22 (5):E12,2007
CONTROLLED HYPERVENTILATION
• A decrease in PaCO2 by 10 mmHg produces proportional decreases in
CBF resulting in rapid and prompt ICP reduction.
• The vasoconstrictive effect of respiratory alkalosis on cerebral
arterioles has been shown to last for 10 to 20 hours
• Beyond which vascular dilation may result in exacerbation of cerebral
edema and rebound elevations in ICP.
Neurosurg Focus 22 (5):E12,2007
TREATMENT
Cerebral Edema
Medical
Osmotherapy Diuretics Corticosteroids Hyperventilation Other Agents
Surgical
OSMOTHERAPY
• The most rapid and effective means of decreasing tissue water and brain bulk.
• Decrease ICP and increase cerebral blood flow.
• Mannitol is the most popular osmotic agent, MOA is unclear,
• IV Mannitol is given in the dosage of 0.25-1.0 g/kg.
• Glycerol is another useful agent given in oral doses of 30 ml every 4-6 hour or
daily IV 50 g in 500 ml of 2.5% saline solution. Used in a dose of 0.5-1.0 g/kg
body weight.
CONTRAINDICATIONS FOR MANNITOL
1. Acute tubular necrosis,
2. Anuria
3. Pulmonary edema;
4. Acute left ventricular failure
5. CHF
6. Cerebral haemorrhage.
SIDE EFFECTS:
DEHYDRATION, HYPERKALEMIA, AND HYPERNATREMIA
Neurosurg Focus 22 (5):E12,2007
THERAPEUTIC BASIS AND GOAL OF
OSMOTHERAPY
• Fundamental goal of osmotherapy is to create an osmotic gradient to
cause egress of water from the brain extracellular (and possibly
intracellular) compartment into the vasculature
• The goal of using osmotherapy is to maintain a euvolemic or a slightly
hypervolemic state.
• A serum osmolality in the range of 300 to 320 mOsm/L has traditionally
been recommended for patients with acute brain injury
Neurosurg Focus 22 (5):E12,2007
HYPERTONIC SALINE
• Unique extraosmotic properties of hypertonic saline
1. Modulation of CSF production resorption
2. Accentuation of tissue oxygen delivery.
3. May modulate inflammatory response.
4. Following brain injury that may act together to ameliorate cerebral edema.
• FORMULATIONS OF HYPERTONIC SALINE
• 2%
• 3% NaCl has 513 mEq/L of Na and Cl.
• 5% NaCl has 856 mEq/L of Na and Cl.
• 7% (1200 mEq/L) and
• 7.5%
• 10%
• 23.4% (approx 4000 mEq/L),
Neurosurg Focus 22 (5):E12,2007
DIURETICS
• The osmotic effect can be prolonged by the use of loop diuretics (Furosemide)
after the osmotic agent infusion. Loop diuretics (Furosemide) can be used as an
adjunct. Furosemide (0.7 mg/kg) has been shown to prolong the reversal of blood
brain osmotic gradient established with the osmotic agents by preferentially
excreting water over solute.
Neurosurg Focus 22 (5):E12,2007
CORTICOSTEROIDS
• Lower intracranial pressure primarily in vasogenic edema because of their
beneficial effect on the blood vessel,
• Less effective in cytotoxic edema, and are not recommended in treatment of
edema secondary to stroke or haemorrhage.
• Inj. Dexamethasone 4-6 mg IM every 4-6 hours.
• Management of malignant brain tumours, either primary or secondary, as
adjuvant chemotherapy of some CNS tumours and perioperatively in brain
surgery
Neurosurg Focus 22 (5):E12,2007
OTHER AGENTS
• Barbiturates, Procaine derivatives, Indomethacin, Propofol and THAM
(Tromethamine), are some other agents which have been tried and used in the
past ,not being used routinely in present practice,
PHARMACOLOGICAL COMA -BARBITURATES
• Barbiturates lower ICP, principally via a reduction in cerebral metabolic
activity, resulting in a coupled reduction in CBF and CBV.
• In patients with TBI, barbiturates are effective in reducing ICP but have
failed to show evidence of improvement in clinical outcome.
• Agents used
• Pentobarbital : a barbiturate with an intermediate physiological half life
(approximately 20 hours) is the preferred agent
• Phenobarbital : which has a much longer half- life (approximately 96 hours)
• Thiopental : which has a much shorter half-life (approximately 5 hours)
Neurosurg Focus 22 (5):E12,2007
ANALGESIA, SEDATION AND PARALYSIS.
• Pain and agitation can worsen cerebral edema and raise ICP significantly,
and should always be controlled.
• Judicious intravenous doses of
• bolus morphine (2–5 mg)
• fentanyl (25– 100 mcg)
• continuous intravenous infusion of fentanyl (25–200 mcg/hour) can be used for
analgesia.
• A NEUROMUSCULAR BLOCKADE:
• can be used as an adjunct to other measures when controlling refractory ICP.
• Nondepolarizing agents should be used, because a depolarizing agent (such
as succinylcholine) can cause elevations in ICP due to induction of muscle
contraction.
Neurosurg Focus 22 (5):E12,2007
THERAPEUTIC HYPOTHERMIA
• Hyperthermia is deleterious to brain injury, achieving normothermia is a
desirable goal in clinical practice.
• External cooling devices
• air-circulating cooling blankets
• iced gastric lavage
• surface ice packs
Neurosurg Focus 22 (5):E12,2007
OTHER ADJUNCT THERAPIES
• HYPERBARIC OXYGEN:
• For the treatment of cerebral edema, based on a clinical trial (100% oxygen at
1.5 atmospheres for 1 hour every 8 hours) that demonstrated enhanced
survival in patients with TBI
• INDOMETHACIN:
• Although the mechanisms are poorly understood, indomethacin treatment has
been shown to attenuate increases in ICP in Traumatic Brain Injury and fever
prevention
Neurosurg Focus 22 (5):E12,2007
SURGERY
• Surgical treatment is occasionally recommended for large hemispherical infarcts
with edema and life threatening brain-shifts.
• Temporary ventriculostomy or craniectomy may prevent deterioration and may
be lifesaving.
• Decompressive craniectomy in the setting of acute brain swelling from cerebral
infarction is a life saving procedure and should be considered in younger patients
who have a rapidly deteriorating neurological status.
• Severe Hydrocephaus- Ventriculo Peritoneal shunt.
Bradley’s Neurology in Clinical Practice,6th
REFERENCES
• Bradley’s Neurology in clinical practice 6th Edition
• Medical Journal Of Armed Forces Of India
• Brain Trauma Foundation Guidelines
• Neurosurg Focus 22 (5):E12,2007
THANK YOU

More Related Content

What's hot

Hemorrhagic stroke
Hemorrhagic stroke Hemorrhagic stroke
Hemorrhagic stroke
Helao Silas
 
Idiopathic Intracranial Hypertension
Idiopathic Intracranial HypertensionIdiopathic Intracranial Hypertension
Idiopathic Intracranial Hypertension
Srirama Anjaneyulu
 
Status Epilepticus
Status EpilepticusStatus Epilepticus
Status Epilepticus
Zeeshan Khan
 
Hypertonic Saline Versus Mannitol for Increased Intracranial Pressure Management
Hypertonic Saline Versus Mannitol for Increased Intracranial Pressure ManagementHypertonic Saline Versus Mannitol for Increased Intracranial Pressure Management
Hypertonic Saline Versus Mannitol for Increased Intracranial Pressure Management
Ade Wijaya
 
Subacute Sclerosing Panencephalitis
Subacute Sclerosing Panencephalitis Subacute Sclerosing Panencephalitis
Subacute Sclerosing Panencephalitis
Ade Wijaya
 
False localising signs : a major examination finding
False localising signs : a major examination findingFalse localising signs : a major examination finding
False localising signs : a major examination finding
Chetan Ganteppanavar
 
Increased Intracranial Pressure
Increased Intracranial PressureIncreased Intracranial Pressure
Increased Intracranial PressureTosca Torres
 
Epidural hematoma
Epidural hematomaEpidural hematoma
Epidural hematoma
PratikDhabalia
 
Stroke localization
Stroke localizationStroke localization
Herniation Syndromes
Herniation SyndromesHerniation Syndromes
Herniation Syndromes
CSN Vittal
 
Posterior circulation stroke
Posterior circulation strokePosterior circulation stroke
Posterior circulation strokeSarath Cherukuri
 
CEREBRAL VENOUS THROMBOSIS
CEREBRAL VENOUS THROMBOSISCEREBRAL VENOUS THROMBOSIS
CEREBRAL VENOUS THROMBOSIS
Nija Panchal
 
Hypoxic ischemic encephalopathy
Hypoxic ischemic encephalopathyHypoxic ischemic encephalopathy
Hypoxic ischemic encephalopathy
Sucharita Ray
 
Cerebral oedema
Cerebral oedema Cerebral oedema
Cerebral oedema drnaveent
 
coma
comacoma
Subarachnoid hemorrhage
Subarachnoid hemorrhageSubarachnoid hemorrhage
Subarachnoid hemorrhageairwave12
 
Approach to seizure
Approach to seizureApproach to seizure
Approach to seizure
biplave karki
 

What's hot (20)

Intracerebral hemorrhage
Intracerebral hemorrhageIntracerebral hemorrhage
Intracerebral hemorrhage
 
Hemorrhagic stroke
Hemorrhagic stroke Hemorrhagic stroke
Hemorrhagic stroke
 
Idiopathic Intracranial Hypertension
Idiopathic Intracranial HypertensionIdiopathic Intracranial Hypertension
Idiopathic Intracranial Hypertension
 
Status Epilepticus
Status EpilepticusStatus Epilepticus
Status Epilepticus
 
Hypertonic Saline Versus Mannitol for Increased Intracranial Pressure Management
Hypertonic Saline Versus Mannitol for Increased Intracranial Pressure ManagementHypertonic Saline Versus Mannitol for Increased Intracranial Pressure Management
Hypertonic Saline Versus Mannitol for Increased Intracranial Pressure Management
 
Subacute Sclerosing Panencephalitis
Subacute Sclerosing Panencephalitis Subacute Sclerosing Panencephalitis
Subacute Sclerosing Panencephalitis
 
False localising signs : a major examination finding
False localising signs : a major examination findingFalse localising signs : a major examination finding
False localising signs : a major examination finding
 
Increased Intracranial Pressure
Increased Intracranial PressureIncreased Intracranial Pressure
Increased Intracranial Pressure
 
Epidural hematoma
Epidural hematomaEpidural hematoma
Epidural hematoma
 
Stroke localization
Stroke localizationStroke localization
Stroke localization
 
Herniation Syndromes
Herniation SyndromesHerniation Syndromes
Herniation Syndromes
 
Posterior circulation stroke
Posterior circulation strokePosterior circulation stroke
Posterior circulation stroke
 
CEREBRAL VENOUS THROMBOSIS
CEREBRAL VENOUS THROMBOSISCEREBRAL VENOUS THROMBOSIS
CEREBRAL VENOUS THROMBOSIS
 
Hypoxic ischemic encephalopathy
Hypoxic ischemic encephalopathyHypoxic ischemic encephalopathy
Hypoxic ischemic encephalopathy
 
Subdural Hematoma
Subdural HematomaSubdural Hematoma
Subdural Hematoma
 
Cerebral oedema
Cerebral oedema Cerebral oedema
Cerebral oedema
 
coma
comacoma
coma
 
Brain abscess (dr. mahesh)
Brain abscess (dr. mahesh)Brain abscess (dr. mahesh)
Brain abscess (dr. mahesh)
 
Subarachnoid hemorrhage
Subarachnoid hemorrhageSubarachnoid hemorrhage
Subarachnoid hemorrhage
 
Approach to seizure
Approach to seizureApproach to seizure
Approach to seizure
 

Similar to Cerebral Edema

CEREBRAL EDEMA.pptx
CEREBRAL EDEMA.pptxCEREBRAL EDEMA.pptx
CEREBRAL EDEMA.pptx
PragyanParamitaSatap
 
light blue creative modern medical clinic presentation.pptx
light blue creative modern medical clinic presentation.pptxlight blue creative modern medical clinic presentation.pptx
light blue creative modern medical clinic presentation.pptx
ShawnManuel7
 
CSF. Anaesthesia
CSF. Anaesthesia CSF. Anaesthesia
CSF. Anaesthesia
Soumya Nath Maiti
 
Cerebral edema
Cerebral edemaCerebral edema
Cerebral edema
ShreyaYadav35
 
Pathophysioloy of stroke
Pathophysioloy of strokePathophysioloy of stroke
Pathophysioloy of stroke
CLINICA VASCULAR DE CALI
 
cerebral ischemia and infarction.pptx
cerebral ischemia and infarction.pptxcerebral ischemia and infarction.pptx
cerebral ischemia and infarction.pptx
vinay nandimalla
 
Management of Cerebral edema.pptx
Management of Cerebral edema.pptxManagement of Cerebral edema.pptx
Management of Cerebral edema.pptx
ChirayuRegmi2
 
Management of Stroke.
Management of Stroke.Management of Stroke.
Management of Stroke.
George Kariuki
 
Nursing management of the client with increased intracranial pressure
Nursing management of the client with increased intracranial pressureNursing management of the client with increased intracranial pressure
Nursing management of the client with increased intracranial pressure
ANILKUMAR BR
 
INCREASED INTRACRANIAL PRESSURE
INCREASED INTRACRANIAL PRESSUREINCREASED INTRACRANIAL PRESSURE
INCREASED INTRACRANIAL PRESSURE
Dr. Binu Babu Nursing Lectures Incredibly Easy
 
Management of Raised Intracranial Pressure
Management of Raised Intracranial PressureManagement of Raised Intracranial Pressure
Management of Raised Intracranial Pressure
Stephanie Okeleke
 
Increased intracranial pressure
Increased intracranial pressureIncreased intracranial pressure
Increased intracranial pressure
Shweta Sharma
 
Nursing management client with Increased intracranial pressure ( ICP)
Nursing management client with Increased intracranial pressure ( ICP)Nursing management client with Increased intracranial pressure ( ICP)
Nursing management client with Increased intracranial pressure ( ICP)
ANILKUMAR BR
 
begnin intracranial hypertension.pptx
begnin intracranial hypertension.pptxbegnin intracranial hypertension.pptx
begnin intracranial hypertension.pptx
hadisadiq
 
Bengin intracranial hypertension.pptx
Bengin intracranial hypertension.pptxBengin intracranial hypertension.pptx
Bengin intracranial hypertension.pptx
hadisadiq
 
1011shock-161227090739.pdf
1011shock-161227090739.pdf1011shock-161227090739.pdf
1011shock-161227090739.pdf
Aditya Raghav
 
10 &11 shock
10 &11 shock10 &11 shock
10 &11 shock
Dr. Haydar Muneer Salih
 
Intracranial hypertensionorhypertension.pptx
Intracranial hypertensionorhypertension.pptxIntracranial hypertensionorhypertension.pptx
Intracranial hypertensionorhypertension.pptx
zamahamch43
 
Pathophysiology Chapter 44
Pathophysiology Chapter 44Pathophysiology Chapter 44
Pathophysiology Chapter 44
TheSlaps
 
SHOCK IN CHILDREN.pptx
SHOCK IN CHILDREN.pptxSHOCK IN CHILDREN.pptx
SHOCK IN CHILDREN.pptx
Dr. Adamu Ibrahim
 

Similar to Cerebral Edema (20)

CEREBRAL EDEMA.pptx
CEREBRAL EDEMA.pptxCEREBRAL EDEMA.pptx
CEREBRAL EDEMA.pptx
 
light blue creative modern medical clinic presentation.pptx
light blue creative modern medical clinic presentation.pptxlight blue creative modern medical clinic presentation.pptx
light blue creative modern medical clinic presentation.pptx
 
CSF. Anaesthesia
CSF. Anaesthesia CSF. Anaesthesia
CSF. Anaesthesia
 
Cerebral edema
Cerebral edemaCerebral edema
Cerebral edema
 
Pathophysioloy of stroke
Pathophysioloy of strokePathophysioloy of stroke
Pathophysioloy of stroke
 
cerebral ischemia and infarction.pptx
cerebral ischemia and infarction.pptxcerebral ischemia and infarction.pptx
cerebral ischemia and infarction.pptx
 
Management of Cerebral edema.pptx
Management of Cerebral edema.pptxManagement of Cerebral edema.pptx
Management of Cerebral edema.pptx
 
Management of Stroke.
Management of Stroke.Management of Stroke.
Management of Stroke.
 
Nursing management of the client with increased intracranial pressure
Nursing management of the client with increased intracranial pressureNursing management of the client with increased intracranial pressure
Nursing management of the client with increased intracranial pressure
 
INCREASED INTRACRANIAL PRESSURE
INCREASED INTRACRANIAL PRESSUREINCREASED INTRACRANIAL PRESSURE
INCREASED INTRACRANIAL PRESSURE
 
Management of Raised Intracranial Pressure
Management of Raised Intracranial PressureManagement of Raised Intracranial Pressure
Management of Raised Intracranial Pressure
 
Increased intracranial pressure
Increased intracranial pressureIncreased intracranial pressure
Increased intracranial pressure
 
Nursing management client with Increased intracranial pressure ( ICP)
Nursing management client with Increased intracranial pressure ( ICP)Nursing management client with Increased intracranial pressure ( ICP)
Nursing management client with Increased intracranial pressure ( ICP)
 
begnin intracranial hypertension.pptx
begnin intracranial hypertension.pptxbegnin intracranial hypertension.pptx
begnin intracranial hypertension.pptx
 
Bengin intracranial hypertension.pptx
Bengin intracranial hypertension.pptxBengin intracranial hypertension.pptx
Bengin intracranial hypertension.pptx
 
1011shock-161227090739.pdf
1011shock-161227090739.pdf1011shock-161227090739.pdf
1011shock-161227090739.pdf
 
10 &11 shock
10 &11 shock10 &11 shock
10 &11 shock
 
Intracranial hypertensionorhypertension.pptx
Intracranial hypertensionorhypertension.pptxIntracranial hypertensionorhypertension.pptx
Intracranial hypertensionorhypertension.pptx
 
Pathophysiology Chapter 44
Pathophysiology Chapter 44Pathophysiology Chapter 44
Pathophysiology Chapter 44
 
SHOCK IN CHILDREN.pptx
SHOCK IN CHILDREN.pptxSHOCK IN CHILDREN.pptx
SHOCK IN CHILDREN.pptx
 

Recently uploaded

Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
Nguyễn Thị Vân Anh
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
AnushriSrivastav
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
pubrica101
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
ssuser787e5c1
 
QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020
Azreen Aj
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
The Harvest Clinic
 
Overcome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptxOvercome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptx
renewlifehypnosis
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
TheDocs
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
RitonDeb1
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
Sachin Sharma
 
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.pptGENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
Mangaiarkkarasi
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
priyabhojwani1200
 
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfNavigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
Enterprise Wired
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
Iris Thiele Isip-Tan
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
Iris Thiele Isip-Tan
 
Preventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & TreatmentPreventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & Treatment
LAB Sports Therapy
 

Recently uploaded (20)

Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
 
QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
 
Overcome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptxOvercome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptx
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
 
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.pptGENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
 
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfNavigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
 
Preventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & TreatmentPreventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & Treatment
 

Cerebral Edema

  • 1. CEREBRAL EDEMA GUIDE: DR.NAVEEN ANGADI CO-GUIDE: DR. ARCHANA UPPIN
  • 2. • Brain tissue, which is composed of 80% water, is separated from the systemic circulation by a complex series of interfaces. • The major site is the endothelial cells that are a component of the neurovascular unit • Cells that form these interfaces have specialized proteins that form tight junctions; some have carrier proteins that shuttle essential molecules, and multiple electrolyte pumps on cell membranes. • Cellular membranes preserve the compartmental structure with water in extracellular and intracellular spaces. INTRODUCTION Bradley’s Neurology in Clinical Practice,6th
  • 3. THE NEURO-VASCULAR UNIT Bradley’s Neurology in Clinical Practice,6th
  • 4. Interface Tight-Junction Location Functional Aspects Blood-CSF Choroid plexus cell Active secretion of CSF via ATPase and carbonic anhydrase CSF-blood Arachnoid membrane Arachnoid granulations absorb CSF by one-way valve mechanism Blood-brain Capillary endothelial cell Active transport of ISF via ATPase; increased mitochondria and glucose transporters in capillary endothelial Bradley’s Neurology in Clinical Practice,6th ATPase, Adenosine triphosphatase; CSF, cerebrospinal fluid; ISF, interstitial fluid.
  • 5. • Brain edema is a common term to describe events related to brain insults. • When shifts in water from one compartment to another occur under pathological conditions, swelling in the various compartments leads to increased intracranial pressure (ICP). • Edema represents a serious, often life threatening consequence of many common brain disorders including stroke, trauma, tumors, and infection. • Cerebral edema is the end result of many neurological diseases. Excess fluid can accumulate in the intracellular or extracellular spaces. Bradley’s Neurology in Clinical Practice,6th
  • 6. CLASSIFICATION • A convenient (though simplified) classification separates brain edema into Cytotoxic or cellular swelling , and Vasogenic or vascular leakage (Klatzo, 1967). • Another proposed category is Interstitial edema , which represents the accumulation of fluid in interstitial spaces in hydrocephalus (Fishman,1975). Bradley’s Neurology in Clinical Practice,6th
  • 7. ETIOLOGY Type Cause Cytotoxic Ischemia, trauma, toxins, metabolic diseases Vasogenic Infections, brain tumors, hyperosmolar states, inflammation Interstitial Hydrocephalus with transependymal flow Bradley’s Neurology in Clinical Practice,6th
  • 8. MOLECULAR CASCADE IN INJURY • Cytotoxic edema, which results from pathological processes that damage cell membranes, constricts the extracellular spaces, constraining movement of fluid between the cells. • Disruption of the BBB leads to vasogenic edema, which expands the extracellular space. Vasogenic edema moves more readily in between the linearly arranged fibers that form the white matter. The gray matter restricts water movement because of the dense nature of the neuropil. • Because of the lack of cell damage in vasogenic edema, once the damage to the blood vessel resolves, there may be a return to normal in the edematous tissue. This is generally not the case in cytotoxic edema, which is due to direct injury to cells. Bradley’s Neurology in Clinical Practice,6th
  • 9. MOLECULAR CASCADE IN INJURY Bradley’s Neurology in Clinical Practice,6th
  • 10. CYTOTOXIC EDEMA • Stroke, trauma, and toxins induce cytotoxic edema. After a stroke, brain water increases rapidly owing to energy failure and loss of ATP. Cytotoxic edema is seen between 24 and 72 hours after the stroke, when the danger of brain herniation is greatest. • Damage to the blood vessels, resulting in vasogenic edema, occurs at multiple times after the insult. In brain trauma, there is an early opening of the BBB along with extensive damage to the brain tissue, and a mixture of cytotoxic and vasogenic edema leads to severe brain edema in the early stages after injury. • Greater damage occurs in transient ischemia, because the restoration of blood flow returns oxygen and white blood cells to the region, enhancing the damage. Reperfusion injury particularly damages the capillary, with disruption of the BBB. Bradley’s Neurology in Clinical Practice,6th
  • 11. VASOGENIC EDEMA • Occurs when there is damage to the capillary and subsequent disruption of the BBB. • Tight junctions in the endothelial cells are the first line of protection. • Protein and blood products enter brain tissue, increasing the oncotic pressure in the brain and exposing brain cells to toxic products from the blood. • Bacterial meningitis initiates an inflammatory response in the meninges caused by the invading organisms and by the secondary release of cytokines and chemokines. The secondary inflammatory response may aggravate the infection. Bradley’s Neurology in Clinical Practice,6th
  • 12. BLOOD PRESSURE AND OSMOLALITY CHANGES ON BRAIN EDEMA • Cerebral blood pressure is tightly regulated in the waking state to ensure adequate flow to the brain. Loss of autoregulation occurs at both the lower and upper extremes of blood pressure, with resulting syncope and hypertensive encephalitis, respectively. • Rapid elevation of blood pressure causes hypertensive encephalopathy. In experimental animals, hyperemia is present, suggesting that the blood vessels are dilated and have increased permeability, • MRI shows vasogenic edema, primarily in the posterior white matter of the brain, a condition referred to by some as reversible posterior leukoencephalopathy syndrome, Bradley’s Neurology in Clinical Practice,6th
  • 13. BLOOD PRESSURE AND OSMOLALITY CHANGES ON BRAIN EDEMA • Another cause of cerebral edema is a rapid change in serum osmolality. • Rapid reduction of plasma glucose and sodium puts patients treated for diabetic ketoacidosis at risk for edema secondary to water shifts into the brain. • Cerebral edema is a complication of acute mountain sickness, which in rare circumstances may be life threatening. Cerebral symptoms are prominent, and there is an increase in cerebral blood volume related to the hypoxia. Bradley’s Neurology in Clinical Practice,6th
  • 14. EDEMA IN VENOUS OCCLUSION AND INTRACEREBRAL HEMORRHAGE • Occlusion of the venous sinuses draining the brain can cause increased ICP and venous hemorrhagic infarction. • Intracerebral hemorrhage (ICH) causes brain edema around the hemorrhagic mass. • This edema is both cytotoxic and vasogenic. • Blood contains coagulation cascade enzymes such as thrombin and plasmin which can damage cells both directly by their toxic effects and indirectly by activation of other proteases. Bradley’s Neurology in Clinical Practice,6th
  • 15. GENERAL MEASURES FOR MANAGING CEREBRAL EDEMA 1. Optimizing Head and Neck Positions 2. Ventilation and Oxygenation 3. Intravascular Volume and Cerebral Perfusion 4. Seizure Prophylaxis 5. Management of Fever and Hyperglycemia 6. Nutritional Support Neurosurg Focus 22 (5):E12,2007
  • 16. OPTIMIZING HEAD AND NECK POSITIONS • 30 ̊elevation of the head in patients is essential for 1. avoiding jugular compression and impedance of venous outflow from the cranium 2. for decreasing CSF hydrostatic pressure.. • Head position elevation may be detrimental in ischemic stroke, because it may compromise perfusion to ischemic tissue at risk. Neurosurg Focus 22 (5):E12,2007
  • 17. VENTILATION AND OXYGENATION • Hypoxia and hypercapnia are potent cerebral vasodilator • Patient should be intubated in: 1. GCS scores less than or equal to 8 2. Patients with poor upper airway reflexes be intubated preemptively for airway protection. 3. Aspiration pneumonitis 4. Pulmonary contusion 5. Acute respiratory distress syndrome. Neurosurg Focus 22 (5):E12,2007
  • 18. INTRAVASCULAR VOLUME AND CEREBRAL PERFUSION • Maintenance of CPP using adequate fluid management in combination with vasopressors is vital in patients with brain injury • Hypotonic fluids should be avoided at all cost • Euvolemia or mild hypervolemia with the use of isotonic fluids (0.9% saline) should always be maintained through rigorous attention to daily fluid balance, body weight, and serum electrolyte monitoring. Neurosurg Focus 22 (5):E12,2007
  • 19. TREATING HYPERTENSION • Judicious use of antihypertensives 1. Labetalol 2. Enalapril 3. Nicardipine is recommended for treating systemic hypertension. • Potent vasodilators are to be avoided • Nitroglycerine • Nitroprusside • as they may exacerbate cerebral edema via accentuated cerebral hyperemia and CBV due to their direct vasodilating effects on cerebral vasculature. Neurosurg Focus 22 (5):E12,2007
  • 20. CONTROLLED HYPERVENTILATION • A decrease in PaCO2 by 10 mmHg produces proportional decreases in CBF resulting in rapid and prompt ICP reduction. • The vasoconstrictive effect of respiratory alkalosis on cerebral arterioles has been shown to last for 10 to 20 hours • Beyond which vascular dilation may result in exacerbation of cerebral edema and rebound elevations in ICP. Neurosurg Focus 22 (5):E12,2007
  • 21. TREATMENT Cerebral Edema Medical Osmotherapy Diuretics Corticosteroids Hyperventilation Other Agents Surgical
  • 22. OSMOTHERAPY • The most rapid and effective means of decreasing tissue water and brain bulk. • Decrease ICP and increase cerebral blood flow. • Mannitol is the most popular osmotic agent, MOA is unclear, • IV Mannitol is given in the dosage of 0.25-1.0 g/kg. • Glycerol is another useful agent given in oral doses of 30 ml every 4-6 hour or daily IV 50 g in 500 ml of 2.5% saline solution. Used in a dose of 0.5-1.0 g/kg body weight.
  • 23. CONTRAINDICATIONS FOR MANNITOL 1. Acute tubular necrosis, 2. Anuria 3. Pulmonary edema; 4. Acute left ventricular failure 5. CHF 6. Cerebral haemorrhage. SIDE EFFECTS: DEHYDRATION, HYPERKALEMIA, AND HYPERNATREMIA Neurosurg Focus 22 (5):E12,2007
  • 24. THERAPEUTIC BASIS AND GOAL OF OSMOTHERAPY • Fundamental goal of osmotherapy is to create an osmotic gradient to cause egress of water from the brain extracellular (and possibly intracellular) compartment into the vasculature • The goal of using osmotherapy is to maintain a euvolemic or a slightly hypervolemic state. • A serum osmolality in the range of 300 to 320 mOsm/L has traditionally been recommended for patients with acute brain injury Neurosurg Focus 22 (5):E12,2007
  • 25. HYPERTONIC SALINE • Unique extraosmotic properties of hypertonic saline 1. Modulation of CSF production resorption 2. Accentuation of tissue oxygen delivery. 3. May modulate inflammatory response. 4. Following brain injury that may act together to ameliorate cerebral edema. • FORMULATIONS OF HYPERTONIC SALINE • 2% • 3% NaCl has 513 mEq/L of Na and Cl. • 5% NaCl has 856 mEq/L of Na and Cl. • 7% (1200 mEq/L) and • 7.5% • 10% • 23.4% (approx 4000 mEq/L), Neurosurg Focus 22 (5):E12,2007
  • 26. DIURETICS • The osmotic effect can be prolonged by the use of loop diuretics (Furosemide) after the osmotic agent infusion. Loop diuretics (Furosemide) can be used as an adjunct. Furosemide (0.7 mg/kg) has been shown to prolong the reversal of blood brain osmotic gradient established with the osmotic agents by preferentially excreting water over solute. Neurosurg Focus 22 (5):E12,2007
  • 27. CORTICOSTEROIDS • Lower intracranial pressure primarily in vasogenic edema because of their beneficial effect on the blood vessel, • Less effective in cytotoxic edema, and are not recommended in treatment of edema secondary to stroke or haemorrhage. • Inj. Dexamethasone 4-6 mg IM every 4-6 hours. • Management of malignant brain tumours, either primary or secondary, as adjuvant chemotherapy of some CNS tumours and perioperatively in brain surgery Neurosurg Focus 22 (5):E12,2007
  • 28. OTHER AGENTS • Barbiturates, Procaine derivatives, Indomethacin, Propofol and THAM (Tromethamine), are some other agents which have been tried and used in the past ,not being used routinely in present practice,
  • 29. PHARMACOLOGICAL COMA -BARBITURATES • Barbiturates lower ICP, principally via a reduction in cerebral metabolic activity, resulting in a coupled reduction in CBF and CBV. • In patients with TBI, barbiturates are effective in reducing ICP but have failed to show evidence of improvement in clinical outcome. • Agents used • Pentobarbital : a barbiturate with an intermediate physiological half life (approximately 20 hours) is the preferred agent • Phenobarbital : which has a much longer half- life (approximately 96 hours) • Thiopental : which has a much shorter half-life (approximately 5 hours) Neurosurg Focus 22 (5):E12,2007
  • 30. ANALGESIA, SEDATION AND PARALYSIS. • Pain and agitation can worsen cerebral edema and raise ICP significantly, and should always be controlled. • Judicious intravenous doses of • bolus morphine (2–5 mg) • fentanyl (25– 100 mcg) • continuous intravenous infusion of fentanyl (25–200 mcg/hour) can be used for analgesia. • A NEUROMUSCULAR BLOCKADE: • can be used as an adjunct to other measures when controlling refractory ICP. • Nondepolarizing agents should be used, because a depolarizing agent (such as succinylcholine) can cause elevations in ICP due to induction of muscle contraction. Neurosurg Focus 22 (5):E12,2007
  • 31. THERAPEUTIC HYPOTHERMIA • Hyperthermia is deleterious to brain injury, achieving normothermia is a desirable goal in clinical practice. • External cooling devices • air-circulating cooling blankets • iced gastric lavage • surface ice packs Neurosurg Focus 22 (5):E12,2007
  • 32. OTHER ADJUNCT THERAPIES • HYPERBARIC OXYGEN: • For the treatment of cerebral edema, based on a clinical trial (100% oxygen at 1.5 atmospheres for 1 hour every 8 hours) that demonstrated enhanced survival in patients with TBI • INDOMETHACIN: • Although the mechanisms are poorly understood, indomethacin treatment has been shown to attenuate increases in ICP in Traumatic Brain Injury and fever prevention Neurosurg Focus 22 (5):E12,2007
  • 33. SURGERY • Surgical treatment is occasionally recommended for large hemispherical infarcts with edema and life threatening brain-shifts. • Temporary ventriculostomy or craniectomy may prevent deterioration and may be lifesaving. • Decompressive craniectomy in the setting of acute brain swelling from cerebral infarction is a life saving procedure and should be considered in younger patients who have a rapidly deteriorating neurological status. • Severe Hydrocephaus- Ventriculo Peritoneal shunt. Bradley’s Neurology in Clinical Practice,6th
  • 34. REFERENCES • Bradley’s Neurology in clinical practice 6th Edition • Medical Journal Of Armed Forces Of India • Brain Trauma Foundation Guidelines • Neurosurg Focus 22 (5):E12,2007

Editor's Notes

  1. Neurons, astrocytes and pericytes form the Neurovascular Unit. On the abluminal surface of the endothelial cells is a thin layer of basal lamina composed of type IV collagen, fibronectin, heparan sulfate, laminin, and entactin. Basal lamina provides structure through type IV collagen, charge barriers by heparan sulfate, and binding sites on the laminin and fibronectin molecules. Within the basal lamina reside the pericytes, which are a combination of smooth muscle and macrophage. Astrocyte foot processes surround the basal lamina. Neurons complete the group of cells that comprise the neurovascular unit Tight junctions (TJ) between the endothelial cells maintain the electrical resistance. A large number of mitochondria are seen in the capillary. Amino acid and glucose transporters are present. Around the cell is a basal lamina composed of type IV collagen, laminin, fibronectin, and heparan sulfate. Astrocytic end-feet surround cells. Pericytes, which are embedded in the basal lamina, are macrophage-like cells that have macrophage and smooth muscle functions in the perivascular space.
  2. Headache Nausea, Vomiting Altered mental status Dizziness, Fainting Blurred vision, Diplopia Urinary incontinence Seizures Coma
  3. Cytotoxic: TBI, SAH, ischemic stroke and ICH,and severe toxic–metabolic derangements (hyponatremia and fulminant hepatic encephalopathy),severe hypothermia, Reye’s Syndrome Vasogenic: Primary and metastatic neoplasms, inflammatory diseases (meningitis, ventriculitis, cerebral abscess, and encephalitis),
  4. Area in the nervous system composed of mostly unmyelinated axons, dendrites and glial cell processes that forms a synaptically dense region containing a relatively low number of cell bodies.
  5. 1)Cellular and blood vessel damage follows activation of an injury cascade. The cascade begins with depletion of energy and glutamate release into the extracellular space which occurs during a hypoxic, ischemic, or traumatic injury and causes cytotoxic damage. Release into the extracellular space of excessive amounts of the excitatory neurotransmitter, glutamate, opens calcium channels on cell membranes, allowing extracellular calcium to enter the brain. 2)The removal of excess calcium from the cell, causes a buildup of sodium within the cell, creating an osmotic gradient that pulls water into the cell. While the cell membrane is intact, the increase in water causes dysfunction but not necessarily permanent damage. Accumulation of calcium ions within the cell activates intracellular cytotoxic processes, leading to cell death. An inflammatory response is initiated by the formation of immediate early genes (e.g., c-fos and c-jun) and cytokines, chemokines, and other intermediary substances. Microglial cells are activated and release free radicals and proteases, which contribute to the attack on cell membranes and capillaries. Irreversible damage to the cell occurs when the integrity of the membrane is lost. Free radicals are pluripotential substances produced in the ischemic brain and after traumatic injury. The arachidonic acid cascade produces reactive oxygen species such as superoxide ion, hydrogen peroxide, and hydroxyl ion. 3)Release of fatty acids provide supply of damaging molecules.
  6. Opening of the BBB could occur by loosening of tight junctions, development of pinocytotic vesicles in the endothelial cell, or an alteration in the basal lamina surrounding the capillaries. 1)Proteases and free radicals are the major substances that attack the capillaries. The layer of basal lamina around the capillary, containing type IV collagen, fibronectin, and laminin, is degraded by proteases. The proteases involved include the serine proteases, plasminogen activators/plasmin system, and matrix metalloproteinases (MMPs). 2)Free radicals activate the proteases and attack the membranes directly .Brain cells and infiltrating leukocytes are the sources of proteases and free radicals. Neutrophils contain prepackaged gelatinase B (MMP-9), which is released at the injury site and activated.
  7. 1) Common causes of rapid elevations of blood pressure are kidney disease, particularly in children with lupus erythematosus or pyelonephritis, and in the pregnancy-induced syndrome of eclampsia. Changes may be transient, and complete recovery is possible if treatment is instituted before hemorrhage or infarction occurs. 2) A characteristic pattern of vasogenic edema without cytotoxic edema is present on MRI: there is extensive edema seen in the white matter, generally in the posterior regions, but spread in frontal regions can be seen, and an absence of DWI lesions indicating this is only vasogenic edema.
  8. Long-standing hyperosmolality leads to solute accumulation in the brain to compensate for hyperosmolar plasma levels. These idiogenic osmoles are thought to include taurine and other amino acids. During treatment of the diabetic ketoacidosis, blood osmolality is reduced, and water moves into brain along the osmotic gradient, resulting in cerebral edema. Rapid reduction of serum hyperosmolality, as in diabetic ketoacidosis, should be avoided to prevent brain edema due to the residual idiogenic osmoles.
  9. Accumulation of blood causes both mass effect on the surrounding tissues and release of toxic blood products into adjacent tissues. Mass effect can lead to herniation.
  10. Target PaCO2 = 35 mm Hg.
  11. Controlled hyperventilation is to be used as a rescue or resuscitative measure for a short duration until more definitive therapiesare instituted and maintained that are tailored toward the particular patient
  12. 1)Thought to decrease brain volume by decreasing overall water content, to reduce blood volume by vasoconstriction, to reduce CSF volume by decreasing water content. Mannitol may exert a protective effect against biochemical injury. 2) When Mannitol is used, one should aim for plasma osmolality 300-320 mOsm/L with maintenance of adequate plasma volume IN PROXIMAL TUBULE: Retains water isoosmotically in PT dilutes luminal fluid which opposes NaCl reabsorption. IN LOOP OF HENLE: Inhibits transport processes in the thick AscLH by an unknown mechanism. Major site of action is LOOP OF HENLE The extraosmotic properties of mannitol have been studied extensively and may provide additional beneficial effects in brain injury, including decreases in blood viscosity, resulting in increases in rCBF and CPP, and a resultant cerebral vasoconstriction leading to decreased CBV, free radical scavenging,and inhibition of apoptosis
  13. An ideal osmotic agent is one that produces a favorable osmotic gradient, is inert and nontoxic, is excluded from an intact BBB, and has minimal systemic side effects. Ability of the intact BBB to exclude a given compound has been quantified (reflection coefficient ). compounds with s approaching 1 (completely impermeable) are considered to be better osmotic agents because they are completely excluded by an intact BBB, and conversely less likely to exhibit “rebound” cerebral edema during withdrawal of osmotherapy. Mannitol= 0.9 ; HTS= 1 With Mannitol, the potential for rebound cerebral edema exists as a result of a reversal of the osmotic gradient between the brain and the intravascular compartment in areas in which the BBB is disrupted
  14. Complications: CNS changes (encephalopathy, lethargy, seizures, coma) central pontine myelinolysis congestive heart failure, pulmonary edema electrolyte derangements (hypokalemia, hypomagnesemia,hypocalcemia) Rate: 1-2 ml/kg/hour.
  15. A common strategy used to raise serum sodium rapidly is to administer an intravenous bolus of furosemide (10 to 20 mg) to enhance free water excretion and to replace it with a 250-ml intravenous bolus of 2 or 3% hypertonic saline.
  16. Precise mechanisms of the beneficial effects of steroids are unknown., steroids decrease tight-junction permeability and, in turn, stabilize the disrupted BBB. Glucocorticoids, especially dexamethasone, are the preferred steroidal agents, due to their low mineralocorticoid activity
  17. 1)Cerebral vasculature is most sensitive to arterial pCO2 changes around the normal level of 40 mm Hg. 2) THAM: tris(hydroxymethyl)-aminomethane, a buffer (pKa ~ 7.8) introduced in the 1960s, which has been shown to ameliorate secondary neuronal injury and cerebral edema, presumably by ameliorating tissue acidosis.
  18. Barbiturates produce a marked decrease in metabolic rate and it seems likely that the fall in cerebral blood flow and ICP is secondary. Complication of barbiturate therapy, in particular systemic hypotension and pulmonary failure.